AKAP8 Antikörper (Middle Region)
Kurzübersicht für AKAP8 Antikörper (Middle Region) (ABIN927323)
Target
Alle AKAP8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Hund, Rind (Kuh)
-
Aufreinigung
- Purified
-
Immunogen
- AKAP8 antibody was raised in rabbit using the middle region of AKAP8 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
AKAP8 Blocking Peptide, (ABIN937603), is also available for use as a blocking control in assays to test for specificity of this AKAP8 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- AKAP8 (A Kinase (PRKA) Anchor Protein 8 (AKAP8))
-
Andere Bezeichnung
- AKAP8
-
Hintergrund
- The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins, which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. AKAP8 is a member of the AKAP family. It is located in the nucleus during interphase and is distinctly redistributed during mitosis. This protein has a cell cycle-dependent interaction with the RII subunit of PKA. Synonyms: Polyclonal AKAP8 antibody, Anti-AKAP8 antibody, A kinase, PRKA anchor protein 8 antibody, AKAP95 antibody, DKFZp586B1222 antibody.
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-